Image: Dr Dorota Pawlak PhD, Director of the Australian Type 1 Diabetes Clinical Research Network

JDRF Australia

The T1DCRN is led by JDRF Australia, whose mission is to find a cure for type 1 diabetes. Corporate Governance of the T1DCRN is provided via the JDRF Board of Directors and the Board T1DCRN Subcommittee.

JDRF International

JDRF International is the world’s largest charitable funder of type 1 diabetes research, with over $160 million in total invested into Australian research to date. The T1DCRN has close colleagial connections with JDRF International, benefitting from their global perspective and knowledge of type 1 diabetes research.

Network Steering Committee

The T1DCRN has attracted leading experts in the field of the type 1 diabetes clinical research. These key opinion leaders have have taken up positions on our Network Steering Committee as advisors, partners, and  ambassadors of the Network.  

The Committee helps to:

  • Ensure that all operational policies and procedures adhere to the T1DCRN’s mission
  • Identify new research partnerships to increase the T1DCRN’s impact
  • Guide the strategic direction and development of the T1DCRN
  • Foster an environment of inclusion and scientific collaboration amongst everyone interested in the T1DCRN

Our Committee members are internationally renowned, Australian expert leaders in type 1 diabetes research. They are:

  • Prof. Peter Colman MBBS, MS, FRACP – University of Melbourne
  • Prof. Mark Cooper MBBS, PhD, FRACP – Monash University
  • Prof. Jennifer Couper MD, FRACP – University of Adelaide
  • A/Prof. Maria Craig MBBS, PhD, FRACP – University of New South Wales
  • Prof. Alicia Jenkins MBBS, MD, MRCP, FRACP, FRCP – University of Sydney
  • Prof. Timothy Jones MBBS, DCH, FRACP, MD – University of Western Australia